Former ghostwriter, Alastair Matheson, talks to BMJ about how the pharmaceutical industry found a loophole to continue composing articles in medical journals without admitting who has actually written the piece. “Numerous articles are produced for journal publication every year, scientific platforms and publications plans are developed, academics are recruited to participate as authors, trade writers draft manuscripts, and substantial payments pass from corporations to agencies, but little of this activity is in the public domain.”
© 2024 Mad in America Foundation